dc.contributor.author |
Elyaman W. |
dc.contributor.author |
Bassil R. |
dc.contributor.author |
Bradshaw E. |
dc.contributor.author |
Orent W. |
dc.contributor.author |
Lahoud Y. |
dc.contributor.author |
Zhu B. |
dc.contributor.author |
Radtke F. |
dc.contributor.author |
Yagita H. |
dc.contributor.author |
Khoury S. |
dc.contributor.editor |
|
dc.date |
Apr-2012 |
dc.date.accessioned |
2017-10-05T15:38:06Z |
dc.date.available |
2017-10-05T15:38:06Z |
dc.date.issued |
2012 |
dc.identifier |
10.1016/j.immuni.2012.01.020 |
dc.identifier.isbn |
|
dc.identifier.issn |
10747613 |
dc.identifier.uri |
http://hdl.handle.net/10938/16132 |
dc.description.abstract |
Interleukin 9 (IL-9) is a pleiotropic cytokine that can regulate autoimmune responses by enhancing regulatory CD4 +FoxP3 + T regulatory (Treg) cell survival and T helper 17 (Th17) cell proliferation. Here, we analyzed the costimulatory requirements for the induction of Th9 cells, and demonstrated that Notch pathway cooperated with TGF-β signaling to induce IL-9. Conditional ablation of Notch1 and Notch2 receptors inhibited the development of Th9 cells. Notch1 intracellular domain (NICD1) recruited Smad3, downstream of TGF-β cytokine signaling, and together with recombining binding protein (RBP)-Jκ bound the Il9 promoter and induced its transactivation. In experimental autoimmune encephalomyelitis (EAE), Jagged2 ligation regulated clinical disease in an IL-9-dependent fashion. Signaling through Jagged2 expanded Treg cells and suppressed EAE when administered before antigen immunization, but worsened EAE when administered concurrently with immunization by favoring Th17 cell expansion. We propose that Notch and Smad3 cooperate to induce IL-9 and participate in regulating the immune response. © 2012 Elsevier Inc.. |
dc.format.extent |
|
dc.format.extent |
Pages: (623-634) |
dc.language |
English |
dc.publisher |
CAMBRIDGE |
dc.relation.ispartof |
Publication Name: Immunity; Publication Year: 2012; Volume: 36; no. 4; Pages: (623-634); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Notch Receptors and Smad3 Signaling Cooperate in the Induction of Interleukin-9-Producing T Cells |
dc.type |
Article |
dc.contributor.affiliation |
Elyaman, W., Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States |
dc.contributor.affiliation |
Bassil, R., Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States |
dc.contributor.affiliation |
Bradshaw, E., Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States |
dc.contributor.affiliation |
Orent, W., Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States |
dc.contributor.affiliation |
Lahoud, Y., Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States |
dc.contributor.affiliation |
Zhu, B., Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States |
dc.contributor.affiliation |
Radtke, F., Ecole Polytechnique Fédérale de Lausanne, Swiss Institute for Experimental Cancer Research, 1066 Epalinges, Switzerland |
dc.contributor.affiliation |
Yagita, H., Department of Immunology, Biomedical Research Center, Juntendo University School of Medicine, Tokyo 113-8421, Japan |
dc.contributor.affiliation |
Khoury, S., Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States, American University of Beirut, Beirut, 1107-2020, Lebanon |
dc.contributor.authorAddress |
Khoury, S.; Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States; email: skhoury@rics.bwh.harvard.edu |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine; Division: Neurology; |
dc.contributor.authorDepartment |
Internal Medicine |
dc.contributor.authorDivision |
Neurology |
dc.contributor.authorEmail |
skhoury@rics.bwh.harvard.edu |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
Elyaman, W |
dc.contributor.authorInitials |
Bassil, R |
dc.contributor.authorInitials |
Bradshaw, EM |
dc.contributor.authorInitials |
Orent, W |
dc.contributor.authorInitials |
Lahoud, Y |
dc.contributor.authorInitials |
Zhu, B |
dc.contributor.authorInitials |
Radtke, F |
dc.contributor.authorInitials |
Yagita, H |
dc.contributor.authorInitials |
Khoury, SJ |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Khoury, SJ (reprint author), Harvard Univ, Sch Med, Brigham and Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
Amsen D, 2009, NAT REV IMMUNOL, V9, P116, DOI 10.1038-nri2488; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016-j.immuni.2007.05.021; Amsen D, 2004, CELL, V117, P515, DOI 10.1016-S0092-8674(04)00451-9; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126-science.1071809; Bassil R, 2011, J IMMUNOL, V187, P2322, DOI 10.4049-jimmunol.1100725; Beriou G, 2010, J IMMUNOL, V185, P46, DOI 10.4049-jimmunol.1000356; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038-nature04753; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083-jcb.200305112; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038-ni.1677; Eller K, 2011, J IMMUNOL, V186, P83, DOI 10.4049-jimmunol.1001183; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073-pnas.0812530106; Elyaman W, 2007, J IMMUNOL, V179, P5990; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016-j.immuni.2007.04.018; Feng LL, 2011, J CLIN IMMUNOL, V31, P1084, DOI 10.1007-s10875-011-9584-9; Fukushima A, 2008, IMMUNOL LETT, V121, P140, DOI 10.1016-j.imlet.2008.10.006; Jager A, 2010, SCAND J IMMUNOL, V72, P173, DOI 10.1111-j.1365-3083.2010.02432.x; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049-jimmunol.0901906; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038-377355a0; Kared H, 2006, IMMUNITY, V25, P823, DOI 10.1016-j.immuni.2006.09.008; Keir ME, 2005, IMMUNOL REV, V204, P128, DOI 10.1111-j.0105-2896.2005.00242.x; Kijima M, 2008, P NATL ACAD SCI USA, V105, P7010, DOI 10.1073-pnas.0709919105; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073-pnas.0809850105; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038-nm1564; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101-gad.13.7.804; Li HM, 2010, J IMMUNOL, V185, P4095, DOI 10.4049-jimmunol.1000986; Locksley RM, 2009, J EXP MED, V206, P1643, DOI 10.1084-jem.20091442; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038-nature05010; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016-S1074-7613(03)00270-X; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038-ni1209; Mukherjee S, 2009, J IMMUNOL, V182, P7381, DOI 10.4049-jimmunol.0804322; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084-jem.20090246; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016-S1074-7613(00)80054-0; RENAULD JC, 1994, ONCOGENE, V9, P1327; Richard M, 2000, P NATL ACAD SCI USA, V97, P767, DOI 10.1073-pnas.97.2.767; Rutz S, 2005, EUR J IMMUNOL, V35, P2443, DOI 10.1002-eji.200526294; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Schroeter EH, 1998, NATURE, V393, P382; Smith SE, 2011, CANCER IMMUNOL IMMUN, V60, P1775, DOI 10.1007-s00262-011-1075-6; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038-nri1845; Stassen M, 2007, MOL IMMUNOL, V44, P926, DOI 10.1016-j.molimm.2006.03.019; Stephens GL, 2011, EUR J IMMUNOL, V41, P952, DOI 10.1002-eji.201040879; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084-jem.20050923; UYTTENHOVE C, 1991, J EXP MED, V173, P519, DOI 10.1084-jem.173.2.519; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038-ni.1659; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016-j.immuni.2008.12.009; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038-icb.2010.53; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016-j.ydbio.2004.01.014 |
dc.description.citedCount |
26 |
dc.description.citedTotWOSCount |
28 |
dc.description.citedWOSCount |
28 |
dc.format.extentCount |
12 |
dc.identifier.articleNo |
|
dc.identifier.coden |
IUNIE |
dc.identifier.pubmedID |
22503540 |
dc.identifier.scopusID |
84859997488 |
dc.identifier.url |
|
dc.publisher.address |
600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Immunity |
dc.relation.ispartOfIssue |
4 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Immunity |
dc.relation.ispartofPubTitleAbbr |
Immunity |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
36 |
dc.source.ID |
WOS:000303223900014 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
|
dc.subject.otherChemCAS |
Smad3 protein, 237417-78-6, 237417-96-8, 237418-00-7 |
dc.subject.otherChemCAS |
Il9r protein, mouse |
dc.subject.otherChemCAS |
Immunoglobulin J Recombination Signal Sequence-Binding Protein |
dc.subject.otherChemCAS |
Interleukin-9 |
dc.subject.otherChemCAS |
Jag2 protein, mouse |
dc.subject.otherChemCAS |
Membrane Proteins |
dc.subject.otherChemCAS |
Notch1 protein, mouse |
dc.subject.otherChemCAS |
Notch2 protein, mouse |
dc.subject.otherChemCAS |
Rbpj protein, mouse |
dc.subject.otherChemCAS |
Receptor, Notch1 |
dc.subject.otherChemCAS |
Receptor, Notch2 |
dc.subject.otherChemCAS |
Receptors, Interleukin-9 |
dc.subject.otherChemCAS |
Smad3 Protein |
dc.subject.otherChemCAS |
Smad3 protein, mouse |
dc.subject.otherChemCAS |
Transforming Growth Factor beta |
dc.subject.otherIndex |
interleukin 9 |
dc.subject.otherIndex |
Jagged1 |
dc.subject.otherIndex |
Jagged2 protein |
dc.subject.otherIndex |
Notch receptor |
dc.subject.otherIndex |
Notch1 receptor |
dc.subject.otherIndex |
Notch2 receptor |
dc.subject.otherIndex |
recombining binding protein Jk |
dc.subject.otherIndex |
Smad3 protein |
dc.subject.otherIndex |
transforming growth factor beta |
dc.subject.otherIndex |
unclassified drug |
dc.subject.otherIndex |
allergic encephalomyelitis |
dc.subject.otherIndex |
animal cell |
dc.subject.otherIndex |
animal experiment |
dc.subject.otherIndex |
animal model |
dc.subject.otherIndex |
antigen immunization |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
cell expansion |
dc.subject.otherIndex |
cell maturation |
dc.subject.otherIndex |
cell stimulation |
dc.subject.otherIndex |
controlled study |
dc.subject.otherIndex |
cytokine production |
dc.subject.otherIndex |
female |
dc.subject.otherIndex |
helper cell |
dc.subject.otherIndex |
immune response |
dc.subject.otherIndex |
immunization |
dc.subject.otherIndex |
immunosuppressive treatment |
dc.subject.otherIndex |
lymphocyte differentiation |
dc.subject.otherIndex |
mouse |
dc.subject.otherIndex |
nonhuman |
dc.subject.otherIndex |
priority journal |
dc.subject.otherIndex |
promoter region |
dc.subject.otherIndex |
protein binding |
dc.subject.otherIndex |
protein domain |
dc.subject.otherIndex |
regulatory T lymphocyte |
dc.subject.otherIndex |
signal transduction |
dc.subject.otherIndex |
T helper 9 cell |
dc.subject.otherIndex |
T lymphocyte |
dc.subject.otherIndex |
Th17 cell |
dc.subject.otherIndex |
transactivation |
dc.subject.otherIndex |
Animals |
dc.subject.otherIndex |
Cell Communication |
dc.subject.otherIndex |
Cell Differentiation |
dc.subject.otherIndex |
Encephalomyelitis, Autoimmune, Experimental |
dc.subject.otherIndex |
Female |
dc.subject.otherIndex |
Immunoglobulin J Recombination Signal Sequence-Binding Protein |
dc.subject.otherIndex |
Interleukin-9 |
dc.subject.otherIndex |
Membrane Proteins |
dc.subject.otherIndex |
Mice |
dc.subject.otherIndex |
Mice, Inbred BALB C |
dc.subject.otherIndex |
Mice, Inbred C57BL |
dc.subject.otherIndex |
Receptor, Notch1 |
dc.subject.otherIndex |
Receptor, Notch2 |
dc.subject.otherIndex |
Receptors, Interleukin-9 |
dc.subject.otherIndex |
Signal Transduction |
dc.subject.otherIndex |
Smad3 Protein |
dc.subject.otherIndex |
T-Lymphocytes, Helper-Inducer |
dc.subject.otherIndex |
T-Lymphocytes, Regulatory |
dc.subject.otherIndex |
Th17 Cells |
dc.subject.otherIndex |
Transforming Growth Factor beta |
dc.subject.otherKeywordPlus |
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS |
dc.subject.otherKeywordPlus |
TGF-BETA |
dc.subject.otherKeywordPlus |
IL-9 PRODUCTION |
dc.subject.otherKeywordPlus |
INTRACELLULAR DOMAIN |
dc.subject.otherKeywordPlus |
GATA3 EXPRESSION |
dc.subject.otherKeywordPlus |
MAST-CELLS |
dc.subject.otherKeywordPlus |
IN-VIVO |
dc.subject.otherKeywordPlus |
DIFFERENTIATION |
dc.subject.otherKeywordPlus |
ACTIVATION |
dc.subject.otherKeywordPlus |
EFFECTOR |
dc.subject.otherWOS |
Immunology |